Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Mistral Pharma has signed a distribution agreement with an undisclosed pharmaceutical company for six injectable generic products for the Canadian market.
Subscribe to our email newsletter
Mistral expects to file these products with Health Canada during 2008. The company estimates that these products target a total market of more than $50 million.
Dalal Manoli, vice president, sales & marketing at Mistral, said: “We are very excited to file these six additional products with Health Canada in 2008. This will strengthen our position as a specialty pharma company with a focus on hospital products.”